Ads
related to: pharmaceutical company marketing strategy
Search results
Results From The WOW.Com Content Network
Pharmaceutical companies are exploring online marketing as an alternative way to reach physicians. Emerging e-promotional activities include live video detailing, online events, electronic sampling, and physician customer service portals such as PV Updates, MDLinx, Aptus Health (former Physicians Interactive), and Epocrates .
In 1996, whistleblower David Franklin left his position as a medical liaison with Parke-Davis, a pharmaceutical division of Warner-Lambert Company, after learning of the company's marketing strategy to promote the epilepsy drug Neurontin for uses not approved by the FDA. [1] Franklin and his attorney, Thomas M. Greene, filed a lawsuit, Franklin v.
Pharmaceutical companies shifted the focus of their marketing efforts to licensed medical doctors in the 1970s, as the FDA mandated that only doctors could prescribe medicine. [8] However, a larger movement towards autonomy in health care decisions prompted the first prominent examples of direct-to-consumer advertising.
Porter noted that between 2013 to 2018, just $2.45 billion was spent on R&D while $4.71 billion was spent on marketing and $334 million on executive compensation.
The ethics involved within pharmaceutical sales is built from the organizational ethics, which is a matter of system compliance, accountability and culture (Grace & Cohen, 2005). Organizational ethics are used when developing the marketing and sales strategy to both the public and the healthcare profession of the strategy. [1]
On average, it takes over a decade and $2.3 billion for a pharmaceutical company to develop a new medication, an expensive slog that few companies want to risk tinkering with. Introducing a new ...
Access to pharmaceutical industry documents has revealed marketing strategies used to promote drugs for off-label use. [3] The United States federal government is aggressively pursuing criminal and civil cases against pharmaceutical companies and their employees for promoting off-label uses of prescription drugs. [4]
Image source: The Motley Fool. Teva Pharmaceutical Industries (NYSE: TEVA) Q4 2024 Earnings Call Jan 29, 2025, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
Ad
related to: pharmaceutical company marketing strategy